AstraZeneca vaccine: Blood clots are "extremely rare" and benefits outweigh risks, regulators conclude. (8th April 2021)

Record Type:
Journal Article
Title:
AstraZeneca vaccine: Blood clots are "extremely rare" and benefits outweigh risks, regulators conclude. (8th April 2021)
Main Title:
AstraZeneca vaccine: Blood clots are "extremely rare" and benefits outweigh risks, regulators conclude
Authors:
Mahase, Elisabeth
Abstract:
Is Part Of:
BMJ. Volume 373(2021)
Journal:
BMJ
Issue:
Volume 373(2021)
Issue Display:
Volume 373, Issue 2021 (2021)
Year:
2021
Volume:
373
Issue:
2021
Issue Sort Value:
2021-0373-2021-0000
Page Start:
Page End:
Publication Date:
2021-04-08
Subjects:
Medicine -- Periodicals
Medicine -- Periodicals
Medicine
Periodicals
610
Journal URLs:
http://www.bmj.com/archive ↗
http://www.jstor.org/journals/09598138.html ↗
http://www.ncbi.nlm.nih.gov/pmc/journals/3/ ↗
http://www.bmj.com/bmj/ ↗
http://www.bmj.com/archive ↗
DOI:
10.1136/bmj.n931 ↗
Languages:
English
ISSNs:
0007-1447
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
17196.xml